Chemoradiation therapy using cyclopamine-loaded liquid-lipid nanoparticles and lutetium-177-labeled core-crosslinked polymeric micelles.

[1]  Ke-kang Sun,et al.  Cyclopamine increases the radiosensitivity of human pancreatic cancer cells by regulating the DNA repair signal pathway through an epidermal growth factor receptor‑dependent pathway. , 2013, Molecular medicine reports.

[2]  W. Weber,et al.  Targeted Radiotherapy of Prostate Cancer with a Gastrin-Releasing Peptide Receptor Antagonist Is Effective as Monotherapy and in Combination with Rapamycin , 2013, The Journal of Nuclear Medicine.

[3]  R. Hales,et al.  Hedgehog pathway inhibition radiosensitizes non-small cell lung cancers. , 2013, International journal of radiation oncology, biology, physics.

[4]  G. Kwon,et al.  Poly(ethylene glycol)-block-poly(ε-caprolactone) micelles for combination drug delivery: evaluation of paclitaxel, cyclopamine and gossypol in intraperitoneal xenograft models of ovarian cancer. , 2013, Journal of controlled release : official journal of the Controlled Release Society.

[5]  S. Fan,et al.  Cyclopamine is a novel Hedgehog signaling inhibitor with significant anti-proliferative, anti-invasive and anti-estrogenic potency in human breast cancer cells , 2013, Oncology letters.

[6]  S. Terry,et al.  Androgens regulate Hedgehog signalling and proliferation in androgen‐dependent prostate cells , 2012, International Journal of Cancer.

[7]  Neeraj Kumar,et al.  Micellar delivery of cyclopamine and gefitinib for treating pancreatic cancer. , 2012, Molecular pharmaceutics.

[8]  R. Baum,et al.  THERANOSTICS: From Molecular Imaging Using Ga-68 Labeled Tracers and PET/CT to Personalized Radionuclide Therapy - The Bad Berka Experience , 2012, Theranostics.

[9]  J. Schneider,et al.  Hedgehog signaling inhibition blocks growth of resistant tumors through effects on tumor microenvironment. , 2012, Cancer research.

[10]  J. Kopeček,et al.  Selective inhibitory effect of HPMA copolymer-cyclopamine conjugate on prostate cancer stem cells. , 2012, Biomaterials.

[11]  Chun Xing Li,et al.  Dual-Modal Tumor Imaging via Long-Circulating Biodegradable Core-Crosslinked Polymeric Micelles. , 2012, ACS macro letters.

[12]  Dong Liang,et al.  Peptide-conjugated polymeric micellar nanoparticles for Dual SPECT and optical imaging of EphB4 receptors in prostate cancer xenografts. , 2011, Biomaterials.

[13]  Yu-Jen Chen,et al.  Sonic hedgehog signaling protects human hepatocellular carcinoma cells against ionizing radiation in an autocrine manner. , 2011, International journal of radiation oncology, biology, physics.

[14]  W. Lu,et al.  Annexin A5–Conjugated Polymeric Micelles for Dual SPECT and Optical Detection of Apoptosis , 2011, The Journal of Nuclear Medicine.

[15]  Malte Buchholz,et al.  Stromal biology and therapy in pancreatic cancer , 2010, Gut.

[16]  E. Tomsits,et al.  Safety and Efficacy of a Lipid Emulsion Containing a Mixture of Soybean Oil, Medium-chain Triglycerides, Olive Oil, and Fish Oil: A Randomised, Double-blind Clinical Trial in Premature Infants Requiring Parenteral Nutrition , 2010, Journal of pediatric gastroenterology and nutrition.

[17]  K. Edlund,et al.  Forkhead box F1 regulates tumor-promoting properties of cancer-associated fibroblasts in lung cancer. , 2010, Cancer research.

[18]  J. D'haese,et al.  Combined targeted treatment to eliminate tumorigenic cancer stem cells in human pancreatic cancer. , 2009, Gastroenterology.

[19]  Bruce H. Hasegawa,et al.  Biodistributions of 177Lu- and 111In-Labeled 7E11 Antibodies to Prostate-Specific Membrane Antigen in Xenograft Model of Prostate Cancer and Potential Use of 111In-7E11 as a Pre-therapeutic Agent for 177Lu-7E11 Radioimmunotherapy , 2009, Molecular Imaging and Biology.

[20]  M. Mullendore,et al.  An orally bioavailable small-molecule inhibitor of Hedgehog signaling inhibits tumor initiation and metastasis in pancreatic cancer , 2008, Molecular Cancer Therapeutics.

[21]  M. Mullendore,et al.  Hedgehog inhibition prolongs survival in a genetically engineered mouse model of pancreatic cancer , 2008, Gut.

[22]  A. Olivi,et al.  Cyclopamine‐Mediated Hedgehog Pathway Inhibition Depletes Stem‐Like Cancer Cells in Glioblastoma , 2007, Stem cells.

[23]  C. Heeschen,et al.  Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. , 2007, Cell stem cell.

[24]  C. Iacobuzio-Donahue,et al.  Blockade of hedgehog signaling inhibits pancreatic cancer invasion and metastases: a new paradigm for combination therapy in solid cancers. , 2007, Cancer research.

[25]  J. Abbruzzese,et al.  Synthetic MicroRNA Designed to Target Glioma-Associated Antigen 1 Transcription Factor Inhibits Division and Induces Late Apoptosis in Pancreatic Tumor Cells , 2006, Clinical Cancer Research.

[26]  J. Ajani,et al.  Hedgehog: an Attribute to Tumor Regrowth after Chemoradiotherapy and a Target to Improve Radiation Response , 2006, Clinical Cancer Research.

[27]  R. Weichselbaum,et al.  Cyclopamine increases the cytotoxic effects of paclitaxel and radiation but not cisplatin and gemcitabine in Hedgehog expressing pancreatic cancer cells , 2006, Cancer Chemotherapy and Pharmacology.

[28]  Masatoshi Nomura,et al.  Hedgehog Signaling Pathway is a New Therapeutic Target for Patients with Breast Cancer , 2004, Cancer Research.

[29]  A. Bruskin,et al.  [177Lu]Bz-DTPA-EGF: Preclinical characterization of a potential radionuclide targeting agent against glioma. , 2004, Cancer biotherapy & radiopharmaceuticals.

[30]  Marina Pasca di Magliano,et al.  Hedgehog signalling in cancer formation and maintenance , 2003, Nature Reviews Cancer.

[31]  Gregory Y. Lauwers,et al.  Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis , 2003, Nature.

[32]  Daniel H Turnbull,et al.  Induction of medulloblastomas in mice by sonic hedgehog, independent of Gli1. , 2002, Cancer research.

[33]  William Gaffield,et al.  Bone patterning is altered in the regenerating zebrafish caudal fin after ectopic expression of sonic hedgehog and bmp2b or exposure to cyclopamine , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[34]  S. Davis,et al.  Lipid Emulsions as Drug Delivery Systems , 1987, Annals of the New York Academy of Sciences.

[35]  F. Melichar,et al.  Preparation and preclinical evaluation of 177Lu-nimotuzumab targeting epidermal growth factor receptor overexpressing tumors. , 2012, Nuclear medicine and biology.

[36]  Xiao-li Zhang,et al.  Hedgehog signaling is activated in subsets of esophageal cancers , 2006, International journal of cancer.

[37]  J. Haveman,et al.  Clonogenic assay of cells in vitro , 2006, Nature Protocols.